BDC Capital's Thrive Venture Fund
Montreal, CanadaFounded 2022
BDC Capital's Thrive Venture Fund is a CAD $300 million direct-investment fund making equity investments in women-led Canadian technology companies at the seed and Series A/B stages. It is part of BDC's $500 million Thrive Platform for Women, launched in 2022 as the successor to the Women in Technology Venture Fund.
Deal activity increased 100% year-over-year (2 deals in the last 12 months). Average disclosed round size is $90.4M (across 12 rounds with reported amounts).
Portfolio
12
Fund Size
$300M
Top Stage
Series B
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Congruence Therapeutics | Series B | $39.5M | Mar 2026 |
 Waabi | Series C | $750M | Jan 2026 |
| KKnead | Pre-Seed | $800K | Jan 2025 |
 Sanctuary | Growth | — | Jul 2024 |
 Odaia | Series B | $25M | May 2023 |
 Vivid Machines | Seed | $4.3M | Apr 2023 |
| Congruence Therapeutics | Series A | $65M | Mar 2023 |
 Symend | Growth | $42M | Nov 2022 |
 Brigit | Series B | $19.4M | Oct 2021 |
| Waabi | Series C | $83.5M | Jun 2021 |
 Blue Dot | Series A | $7M | Jan 2021 |
 Puzzle Medical Devices | Series A | $43M | — |
 Lillio | Series B | — | — |
 FlipGive | Series B | $5M | — |
Top Co-Investors
Radical Ventures2 shared
Khosla Ventures2 shared
Uber Investments2 shared
Tau Ventures2 shared
Lightspeed Venture Partners2 shared
Export Development Canada2 shared
Amplitude Ventures2 shared
OrbiMed2 shared
MaRS IAF2 shared
8VC1 shared
BDC Capital1 shared
OMERS Ventures1 shared
Nyca Partners1 shared
Vanedge Capital1 shared
Sands Capital1 shared
Camber Creek1 shared
Story Ventures1 shared
Nine Four Ventures1 shared
DCM Ventures1 shared
Graphene Ventures1 shared
Last updated: 8 September 2026